Likewise exosome-transmitted lncARSR can promote sunitinib resistance by binding miR-34/miR-449 to facilitate AXL and c-MET expression in renal cancer, acting as a competing endogenous RNA [49]. Here, LNCARSR is linked to renal carcinoma.